Return to homepagePandemic Pact

CREDID COVID-19 ADAPTIVE PLATFORM - RANDOMISED CLINICAL TRIALS

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $750,000

  • Funder

    Lundbeck Foundation

  • Principal Investigator

    N/A

  • Research Location

    Denmark

  • Lead Research Institution

    Hvidovre Hospital

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

It will probably take years to develop an actual vaccine for the COVID-19 virus. A research group at Hvidovre Hospital will therefore investigate whether well-known drugs such as hydroxychloroquine, plasma from people who have recovered from the virus, IL-6 antagonists and baricitinib could have a positive effect on adults with COVID-19 pneumonia.